Our findings are in line with the results of Kokonozaki and co-workers, who described positive correlation of soluble FLT3-L in peripheral blood with the angiogenic process in MM and additional effects on disease activity. The gene discussed is FLT3LG; the disease is Miyoshi myopathy.